1,135
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Single-cell analysis of T lymphocytes infiltrating colorectal carcinoma: the dilemma of specificity

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Khaliq AM, Erdogan C, Kurt Z, Turgut SS, Grunvald MW, Rand T, Khare S, Borgia JA, Hayden DM, Pappas SG, et al. Refining colorectal cancer classification and clinical stratification through a single-cell atlas. Genome Biol. 2022;23(1):113. doi:10.1186/s13059-022-02677-z.
  • Klapp V, Alvarez-Abril B, Leuzzi G, Kroemer G, Ciccia A, Galluzzi L. The DNA damage response and inflammation in cancer. Cancer Discov. 2023;13(7):1521–3. doi:10.1158/2159-8290.CD-22-1220.
  • Le Naour J, Montegut L, Pan Y, Scuderi SA, Cordier P, Joseph A, Sauvat A, Iebba V, Paillet J, Ferrere G, et al. Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis. Oncoimmuno-logy. 2023;12(1):2237354. doi:10.1080/2162402X.2023.2237354.
  • Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Sci. 2006;313(5795):1960–1964. doi:10.1126/science.1129139.
  • Mlecnik B, Lugli A, Bindea G, Marliot F, Bifulco C, Lee JJ, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, et al. Multicenter international study of the consensus immunoscore for the prediction of relapse and survival in Early-Stage colon cancer. Cancers (Basel). 2023;15(2):418. doi:10.3390/cancers15020418.
  • Borras DM, Verbandt S, Ausserhofer M, Sturm G, Lim J, Verge GA, Vanmeerbeek I, Laureano RS, Govaerts J, Sprooten J, et al. Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer. Cell Discov. 2023;9(1):114. doi:10.1038/s41421-023-00605-4.
  • Roelands J, Kuppen PJK, Ahmed EI, Mall R, Masoodi T, Singh P, Monaco G, Raynaud C, de Miranda NFCC, Ferraro L, et al. An integrated tumor, immune and microbiome atlas of colon cancer. Nat Med. 2023;29(5):1273–86. doi:10.1038/s41591-023-02324-5.
  • Petitprez F, Vano YA, Becht E, Giraldo NA, de Reynies A, Sautes-Fridman C, Fridman WH. Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies. Cancer Immunol Immunother. 2018;67(6):981–988. doi:10.1007/s00262-017-2058-z.
  • Zitvogel L, Kroemer G. Cross-reactivity between microbial and tumor antigens. Curr Opin Immunol. 2022;75:102171. doi:10.1016/j.coi.2022.102171.
  • Paillet J, Plantureux C, Levesque S, Le Naour J, Stoll G, Sauvat A, Caudana P, Tosello Boari J, Bloy N, Lachkar S, et al. Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma. J Exp Med. 2021;218(10). doi:10.1084/jem.20200853.